Q4 2018 13F Holders as of 31 Dec 2018
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
19,667,509
-
Total 13F shares
-
26,738,214
-
Share change
-
+2,487,832
-
Total reported value
-
$3,627,706,738
-
Put/Call ratio
-
193%
-
Price per share
-
$135.70
-
Number of holders
-
345
-
Value change
-
+$255,710,799
-
Number of buys
-
197
-
Number of sells
-
169
Institutional Holders of LIGAND PHARMACEUTICALS INC - Common Stock (LGND) as of Q4 2018
As of 31 Dec 2018,
LIGAND PHARMACEUTICALS INC - Common Stock (LGND) was held by
345 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
26,738,214 shares.
The largest 10 holders included
BlackRock Inc., Vanguard Group Inc, RENAISSANCE TECHNOLOGIES LLC, STATE STREET CORP, JANUS HENDERSON GROUP PLC, WILLIAM BLAIR INVESTMENT MANAGEMENT, LLC, AMERIPRISE FINANCIAL INC, MILLENNIUM MANAGEMENT LLC, CARDINAL CAPITAL MANAGEMENT LLC /CT, and Conestoga Capital Advisors, LLC.
This page lists
347
institutional shareholders reporting positions in this security
for the Q4 2018 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.